John Kenneth Jenkins

All filings by John Kenneth Jenkins on record concern Corbus Pharmaceuticals Holdings, Inc. Over a trading history stretching from 15 March 2019 to 10 June 2026, the count stands at 6 filings.

The open-market side counts 1 purchase for €6,172 alongside 2 sales for €51k. Taken together, the sales exceed the purchases by €45k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants. In 2026 alone, the filings show no purchases and 1 sale.

The latest filing, published on 11 June 2026, reports an open-market sale of €33k in Corbus Pharmaceuticals Holdings, Inc. The last insider purchase was made public on 15 March 2019, 2,779 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.